Bruce G. Allen Investments’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.52K Sell
8
-1
-11% -$148 ﹤0.01% 736
2026
Q1
$838 Sell
9
-1
-10% -$89 ﹤0.01% 864
2025
Q4
$803 Hold
10
– – ﹤0.01% 877
2025
Q3
$976 Hold
10
– – ﹤0.01% 827
2025
Q2
$697 Buy
10
+3
+43% +$171 ﹤0.01% 892
2025
Q1
$348 Hold
7
– – ﹤0.01% 1000
2024
Q4
$489 Buy
7
+1
+17% +$83 ﹤0.01% 965
2024
Q3
$629 Buy
+6
New +$702 ﹤0.01% 910

Other funds holding ACLS

Bruce G. Allen Investments's ACLS Position: Q2 2026 in Review

Bruce G. Allen Investments reduced its Axcelis (ACLS) stake by 11% in Q2 2026, selling an estimated $148 and leaving 8 shares worth $1.52K. The position accounts for ﹤0.01% of the portfolio, ranked #736.

Bruce G. Allen Investments first reported a position in ACLS in Q3 2024 and has held it in 8 quarters since. 443 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Bruce G. Allen Investments held 8 shares of Axcelis worth $1.52K as of Q2 2026.
  • Bruce G. Allen Investments sold 1 Axcelis share in Q2 2026, an estimated $148.
  • Axcelis made up ﹤0.01% of Bruce G. Allen Investments's portfolio in Q2 2026, its #736 holding.
  • Bruce G. Allen Investments first reported a position in Axcelis in Q3 2024 and has held it in 8 quarters since.
  • 443 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.